[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention
DJ Angiolillo, M Galli, JP Collet, A Kastrati… - eurointervention.pcronline.com
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
[PDF][PDF] Antiplatelet therapy after percutaneous coronary intervention
DJ Angiolillo - 2022 - researchgate.net
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
[PDF][PDF] Antiplatelet therapy after percutaneous coronary intervention
DJ Angiolillo - 2022 - isoic.org
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
Antiplatelet therapy after percutaneous coronary intervention.
DJ Angiolillo, M Galli, JP Collet, A Kastrati… - … : Journal of Europcr in …, 2022 - europepmc.org
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
Antiplatelet therapy after percutaneous coronary intervention
DA Angiolillo, M Galli, JP Collet, A Kastrati… - EuroIntervention, 2022 - hal.science
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
Antiplatelet therapy after percutaneous coronary intervention
DJ Angiolillo, M Galli, JP Collet… - … of EuroPCR in …, 2022 - pubmed.ncbi.nlm.nih.gov
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
[引用][C] Antiplatelet therapy after percutaneous coronary intervention
DA Angiolillo, M Galli, JP Collet, A Kastrati… - EuroIntervention, 2022 - cir.nii.ac.jp
Antiplatelet therapy after percutaneous coronary intervention | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Antiplatelet therapy after percutaneous coronary intervention.
DJ Angiolillo, M Galli, JP Collet, A Kastrati… - 2022 - mediatum.ub.tum.de
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
Antiplatelet therapy after percutaneous coronary intervention.
DJ Angiolillo, M Galli, JP Collet, A Kastrati… - … : Journal of Europcr in …, 2022 - europepmc.org
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …